US equities |
MU $1,029.00 ▼-0.66% NVDA $229.28 ▼-0.52% SPCX $162.57 ▲+1.25% TSLA $382.70 ▲+2.05% AAPL $336.64 ▼-1.11% MSFT $535.07 ▲+2.38% AMZN $262.43 ▲+3.29% META $718.67 ▼-0.31%
FinancialContent

Moderna, Inc. - Common Stock (NQ:MRNA)

225.00 +28.00 (+14.21%)
Delayed Quote Updated: 4:00 PM EDT, Oct 9, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Moderna, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Which S&P500 stocks are gapping on Thursday? ↗
Via Chartmill
These S&P500 stocks that are showing activity before the opening bell on Thursday. ↗
Via Chartmill
News headline image
Moderna Announces Proposed Private Placement of $2.0 Billion of Convertible Senior Notes
From Moderna, Inc.
Via ACCESS Newswire
What's going on in today's session: S&P500 movers ↗
Via Chartmill
These S&P500 stocks are gapping in today's session ↗
Via Chartmill
Which S&P500 stocks have an unusual volume on Friday? ↗
Via Chartmill
News headline image
A Multibillion-Dollar mRNA Cancer Market Is Taking Shape Targeting Lung Cancer’s Biggest Opportunity
EQNX::TICKER_START (NASDAQ:SBFM),(NASDAQ:BNTX),(NYSE:AZN),(NASDAQ:MRNA),(NYSE:BMY) EQNX::TICKER_END 
Via FinancialNewsMedia
News headline image
A Multibillion-Dollar mRNA Cancer Market Is Taking Shape Targeting Lung Cancer’s Biggest Opportunity
A New Generation of Personalized Cancer Treatments Could Open a Multibillion-Dollar Market for Precision Oncology 
From MarketNewsUpdates.com
Via GlobeNewswire
Top S&P500 movers in Wednesday's pre-market session ↗
Via Chartmill
Top S&P500 movers in Tuesday's session ↗
Via Chartmill
Which S&P500 stocks are the most active on Tuesday? ↗
Via Chartmill
In today's session, these stocks are experiencing unusual volume. ↗
Via Chartmill
Uncover the latest developments among S&P500 stocks in today's session. ↗
Via Chartmill
News headline image
Myriad Genetics and Moderna Shares Plummet, What You Need To Know
What Happened? A number of stocks fell in the afternoon session after shares across biotech and big pharma cooled further as traders continued to secure prof... 
Via StockStory
Stay informed with the top movers within the S&P500 index on Monday. ↗
Via Chartmill
What's going on in today's session: S&P500 most active stocks ↗
Via Chartmill
The trading volume of these stocks is deviating from the norm in today's session. ↗
Via Chartmill
Monday's session: gap up and gap down stock in the S&P500 index ↗
Via Chartmill
News headline image
1 Large-Cap Stock with Impressive Fundamentals and 2 We Turn Down
Large-cap stocks have the power to shape entire industries thanks to their size and widespread influence. With such vast footprints, however, finding new are... 
Via StockStory
News headline image
Why Tempus AI Skyrocketed This Week ↗
Tempus AI's latest acquisition is looking like a great move. 
Via The Motley Fool
Topics Artificial Intelligence Stocks
News headline image
2 Biotech Stocks Shaping Up for Major Breakouts ↗
Moderna's mRNA cancer vaccine breakthrough with Merck fueled a biotech rally, with the IBB near highs. Eli Lilly and Natera both show strong uptrends and possible breakouts. 
Via MarketBeat
Topics ETFs
News headline image
Breakfast News: A Conversation With Ionis CEO ↗
Ionis Pharmaceuticals CEO on a major profitability milestone, breakthrough medicines and more. 
Via The Motley Fool
Topics ETFs World Trade
News headline image
MarketBeat Week in Review – 08/17 - 08/21 ↗
Stocks fell this week as Treasury bond buybacks, oil prices, and Walmart earnings weighed on markets, while Bitcoin rallied; MarketBeat analysts cover Moderna, NVIDIA, Meta, RTX, and more. 
Via MarketBeat
Topics Bonds ETFs Economy
Explore the top gainers and losers within the S&P500 index in today's session. ↗
Via Chartmill
Which S&P500 stocks are the most active on Friday? ↗
Via Chartmill
Friday's session: most active stocks ↗
Via Chartmill
Exploring the top movers within the S&P500 index during today's session. ↗
Via Chartmill
News headline image
Moderna’s 177% Surge Has Investors Asking What Comes Next ↗
Moderna shares surged 177% after its melanoma vaccine, developed with Merck, outperformed an established therapy in a late-stage trial, triggering a massive short squeeze. 
Via MarketBeat
Walmart's Guide-Down Sinks the Dow as Trump Readies an "Economic D-Day" for Iran ↗
Via Chartmill
Topics Government Stocks
News headline image
Moderna's Comeback Is Finally Taking Shape -- and There May Be More Upside Ahead ↗
Breaking news: Moderna isn't just a "pandemic stock" after all. 
Via The Motley Fool
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >